VThunter
a database for single-cell screening of virus target cells in animal kingdom
Chicken

Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Sauropsida; Sauria; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Galloanserae; Galliformes; Phasianidae; Phasianinae; Gallus,

Latin Name: Gallus gallus

Tested tissues: PrimitiveStreak, AnteriorNeuralTube, TotalBrain,

Data set information
Project Date Technology Tissue Condition Cell PMID/DOI
Vthunter_1025 2018.07 Fluidigm C1 PrimitiveStreak Normal 175 Link
Vthunter_1006 2017.12 SMART-seq AnteriorNeuralTube Normal 500 Link
Vthunter_110067 2019.12 MARS-seq TotalBrain Normal 768 Link
Virus Virus Name GeneTop 5 cell types expressing viral receptor ordered by expression proportion
Simian rotavirus A strain RRV
AnteriorNeuralTube-neural crest cell : 100.00% ;
PrimitiveStreak-embryonic cell : 100.00% ;
TotalBrain-Immune cells : 29.43% ;
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 97.01% ;
TotalBrain-Immune cells : 38.93% ;
AnteriorNeuralTube-neural crest cell : 64.07% ;
PrimitiveStreak-embryonic cell : 60.00% ;
TotalBrain-Immune cells : 14.58% ;
AnteriorNeuralTube-neural crest cell : 40.52% ;
PrimitiveStreak-embryonic cell : 22.29% ;
PrimitiveStreak-embryonic cell : 21.71% ;
AnteriorNeuralTube-neural crest cell : 13.57% ;
TotalBrain-Immune cells : 0.00% ;
Foot-and-mouth disease virus
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 97.01% ;
TotalBrain-Immune cells : 38.93% ;
AnteriorNeuralTube-neural crest cell : 64.07% ;
PrimitiveStreak-embryonic cell : 60.00% ;
TotalBrain-Immune cells : 14.58% ;
PrimitiveStreak-embryonic cell : 16.57% ;
AnteriorNeuralTube-neural crest cell : 12.57% ;
TotalBrain-Immune cells : 0.00% ;
PrimitiveStreak-embryonic cell : 12.00% ;
TotalBrain-Immune cells : 0.00% ;
Adeno-associated virus 9
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 99.80% ;
TotalBrain-Immune cells : 1.43% ;
Hepacivirus C
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 94.81% ;
TotalBrain-Immune cells : 20.05% ;
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 79.04% ;
TotalBrain-Immune cells : 0.00% ;
PrimitiveStreak-embryonic cell : 90.29% ;
AnteriorNeuralTube-neural crest cell : 27.94% ;
TotalBrain-Immune cells : 0.52% ;
PrimitiveStreak-embryonic cell : 81.14% ;
AnteriorNeuralTube-neural crest cell : 69.66% ;
TotalBrain-Immune cells : 3.39% ;
AnteriorNeuralTube-neural crest cell : 44.71% ;
PrimitiveStreak-embryonic cell : 40.57% ;
TotalBrain-Immune cells : 0.00% ;
AnteriorNeuralTube-neural crest cell : 18.96% ;
PrimitiveStreak-embryonic cell : 8.00% ;
TotalBrain-Immune cells : 7.03% ;
TotalBrain-Immune cells : 0.00% ;
Chikungunya virus
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 97.60% ;
TotalBrain-Immune cells : 4.43% ;
PrimitiveStreak-embryonic cell : 15.43% ;
AnteriorNeuralTube-neural crest cell : 10.78% ;
TotalBrain-Immune cells : 0.52% ;
Human rotavirus strain WA
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 97.01% ;
TotalBrain-Immune cells : 38.93% ;
AnteriorNeuralTube-neural crest cell : 40.52% ;
PrimitiveStreak-embryonic cell : 22.29% ;
PrimitiveStreak-embryonic cell : 21.71% ;
AnteriorNeuralTube-neural crest cell : 13.57% ;
TotalBrain-Immune cells : 0.00% ;
Classical swine fever virus
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 99.80% ;
TotalBrain-Immune cells : 1.43% ;
Adeno-associated virus - 3
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 99.80% ;
TotalBrain-Immune cells : 1.43% ;
Venezuelan equine encephalitis virus
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 99.80% ;
TotalBrain-Immune cells : 1.43% ;
Human parvovirus B19
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 97.01% ;
TotalBrain-Immune cells : 38.93% ;
Dengue virus
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 79.04% ;
TotalBrain-Immune cells : 0.00% ;
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 99.80% ;
TotalBrain-Immune cells : 1.43% ;
PrimitiveStreak-embryonic cell : 92.57% ;
AnteriorNeuralTube-neural crest cell : 62.87% ;
TotalBrain-Immune cells : 0.39% ;
Human betaherpesvirus 5
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 97.01% ;
TotalBrain-Immune cells : 38.93% ;
PrimitiveStreak-embryonic cell : 90.29% ;
AnteriorNeuralTube-neural crest cell : 27.94% ;
TotalBrain-Immune cells : 0.52% ;
AnteriorNeuralTube-neural crest cell : 64.07% ;
PrimitiveStreak-embryonic cell : 60.00% ;
TotalBrain-Immune cells : 14.58% ;
AnteriorNeuralTube-neural crest cell : 43.31% ;
PrimitiveStreak-embryonic cell : 3.43% ;
TotalBrain-Immune cells : 0.00% ;
Human gammaherpesvirus 4
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 97.01% ;
TotalBrain-Immune cells : 38.93% ;
AnteriorNeuralTube-neural crest cell : 49.70% ;
PrimitiveStreak-embryonic cell : 1.71% ;
TotalBrain-Immune cells : 0.00% ;
PrimitiveStreak-embryonic cell : 1.14% ;
AnteriorNeuralTube-neural crest cell : 1.00% ;
Echovirus E8
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 97.01% ;
TotalBrain-Immune cells : 38.93% ;
PrimitiveStreak-embryonic cell : 21.71% ;
AnteriorNeuralTube-neural crest cell : 13.57% ;
TotalBrain-Immune cells : 0.00% ;
Human metapneumovirus
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 97.01% ;
TotalBrain-Immune cells : 38.93% ;
Adeno-associated virus - 8
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 99.80% ;
TotalBrain-Immune cells : 1.43% ;
Adeno-associated virus - 2
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 99.80% ;
TotalBrain-Immune cells : 1.43% ;
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 97.01% ;
TotalBrain-Immune cells : 38.93% ;
AnteriorNeuralTube-neural crest cell : 79.64% ;
PrimitiveStreak-embryonic cell : 77.71% ;
TotalBrain-Immune cells : 5.47% ;
Echovirus E1
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 97.01% ;
TotalBrain-Immune cells : 38.93% ;
PrimitiveStreak-embryonic cell : 21.71% ;
AnteriorNeuralTube-neural crest cell : 13.57% ;
TotalBrain-Immune cells : 0.00% ;
Equid alphaherpesvirus 1
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 97.01% ;
TotalBrain-Immune cells : 38.93% ;
PrimitiveStreak-embryonic cell : 89.71% ;
AnteriorNeuralTube-neural crest cell : 86.23% ;
TotalBrain-Immune cells : 25.00% ;
Sindbis virus
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 99.80% ;
TotalBrain-Immune cells : 1.43% ;
Lassa mammarenavirus
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 95.61% ;
TotalBrain-Immune cells : 30.73% ;
PrimitiveStreak-embryonic cell : 92.57% ;
AnteriorNeuralTube-neural crest cell : 62.87% ;
TotalBrain-Immune cells : 0.39% ;
PrimitiveStreak-embryonic cell : 83.43% ;
AnteriorNeuralTube-neural crest cell : 50.10% ;
TotalBrain-Immune cells : 2.21% ;
Mammalian orthoreovirus
PrimitiveStreak-embryonic cell : 100.00% ;
AnteriorNeuralTube-neural crest cell : 97.01% ;
TotalBrain-Immune cells : 38.93% ;
AnteriorNeuralTube-neural crest cell : 40.52% ;
PrimitiveStreak-embryonic cell : 22.29% ;
AnteriorNeuralTube-neural crest cell : 32.73% ;
PrimitiveStreak-embryonic cell : 17.14% ;
TotalBrain-Immune cells : 0.00% ;
Feline leukemia virus strain B/lambda-B1
PrimitiveStreak-embryonic cell : 94.29% ;
AnteriorNeuralTube-neural crest cell : 67.86% ;
TotalBrain-Immune cells : 1.17% ;
AnteriorNeuralTube-neural crest cell : 47.11% ;
PrimitiveStreak-embryonic cell : 13.71% ;
TotalBrain-Immune cells : 0.65% ;
Amphotropic murine leukemia virus
PrimitiveStreak-embryonic cell : 94.29% ;
AnteriorNeuralTube-neural crest cell : 67.86% ;
TotalBrain-Immune cells : 1.17% ;
Gibbon ape leukemia virus
PrimitiveStreak-embryonic cell : 94.29% ;
AnteriorNeuralTube-neural crest cell : 67.86% ;
TotalBrain-Immune cells : 1.17% ;
AnteriorNeuralTube-neural crest cell : 47.11% ;
PrimitiveStreak-embryonic cell : 13.71% ;
TotalBrain-Immune cells : 0.65% ;
Rabies lyssavirus
PrimitiveStreak-embryonic cell : 93.71% ;
AnteriorNeuralTube-neural crest cell : 85.63% ;
TotalBrain-Immune cells : 0.78% ;
AnteriorNeuralTube-neural crest cell : 26.15% ;
PrimitiveStreak-embryonic cell : 4.00% ;
TotalBrain-Immune cells : 2.34% ;
TotalBrain-Immune cells : 0.00% ;
Marburg marburgvirus
PrimitiveStreak-embryonic cell : 92.57% ;
AnteriorNeuralTube-neural crest cell : 62.87% ;
TotalBrain-Immune cells : 0.39% ;
AnteriorNeuralTube-neural crest cell : 61.08% ;
PrimitiveStreak-embryonic cell : 52.57% ;
TotalBrain-Immune cells : 6.12% ;
Lymphocytic choriomeningitis mammarenavirus
PrimitiveStreak-embryonic cell : 92.57% ;
AnteriorNeuralTube-neural crest cell : 62.87% ;
TotalBrain-Immune cells : 0.39% ;
PrimitiveStreak-embryonic cell : 83.43% ;
AnteriorNeuralTube-neural crest cell : 50.10% ;
TotalBrain-Immune cells : 2.21% ;
Ebola virus
PrimitiveStreak-embryonic cell : 92.57% ;
AnteriorNeuralTube-neural crest cell : 62.87% ;
TotalBrain-Immune cells : 0.39% ;
AnteriorNeuralTube-neural crest cell : 66.07% ;
PrimitiveStreak-embryonic cell : 61.71% ;
TotalBrain-Immune cells : 1.17% ;
AnteriorNeuralTube-neural crest cell : 61.08% ;
PrimitiveStreak-embryonic cell : 52.57% ;
TotalBrain-Immune cells : 6.12% ;
Zika virus
PrimitiveStreak-embryonic cell : 92.57% ;
AnteriorNeuralTube-neural crest cell : 62.87% ;
TotalBrain-Immune cells : 0.39% ;
Polytropic murine leukemia virus
AnteriorNeuralTube-neural crest cell : 90.82% ;
PrimitiveStreak-embryonic cell : 82.29% ;
TotalBrain-Immune cells : 2.08% ;
Xenotropic murine leukemia virus
AnteriorNeuralTube-neural crest cell : 90.82% ;
PrimitiveStreak-embryonic cell : 82.29% ;
TotalBrain-Immune cells : 2.08% ;
Influenza A virus
PrimitiveStreak-embryonic cell : 90.29% ;
AnteriorNeuralTube-neural crest cell : 27.94% ;
TotalBrain-Immune cells : 0.52% ;
AnteriorNeuralTube-neural crest cell : 80.64% ;
PrimitiveStreak-embryonic cell : 78.29% ;
TotalBrain-Immune cells : 1.82% ;
AnteriorNeuralTube-neural crest cell : 45.11% ;
PrimitiveStreak-embryonic cell : 26.29% ;
TotalBrain-Immune cells : 4.04% ;
PrimitiveStreak-embryonic cell : 32.00% ;
AnteriorNeuralTube-neural crest cell : 30.54% ;
Human immunodeficiency virus 1
AnteriorNeuralTube-neural crest cell : 86.03% ;
PrimitiveStreak-embryonic cell : 84.00% ;
TotalBrain-Immune cells : 6.64% ;
TotalBrain-Immune cells : 20.83% ;
Feline immunodeficiency virus
AnteriorNeuralTube-neural crest cell : 86.03% ;
PrimitiveStreak-embryonic cell : 84.00% ;
TotalBrain-Immune cells : 6.64% ;
Human immunodeficiency virus 2
AnteriorNeuralTube-neural crest cell : 86.03% ;
PrimitiveStreak-embryonic cell : 84.00% ;
TotalBrain-Immune cells : 6.64% ;
Varicella Zoster Virus
PrimitiveStreak-embryonic cell : 85.71% ;
AnteriorNeuralTube-neural crest cell : 81.44% ;
TotalBrain-Immune cells : 2.34% ;
Human alphaherpesvirus 3
PrimitiveStreak-embryonic cell : 85.71% ;
AnteriorNeuralTube-neural crest cell : 81.44% ;
TotalBrain-Immune cells : 2.34% ;
Hendra henipavirus
PrimitiveStreak-embryonic cell : 83.43% ;
AnteriorNeuralTube-neural crest cell : 32.34% ;
TotalBrain-Immune cells : 0.00% ;
Latino mammarenavirus
PrimitiveStreak-embryonic cell : 83.43% ;
AnteriorNeuralTube-neural crest cell : 50.10% ;
TotalBrain-Immune cells : 2.21% ;
Oliveros mammarenavirus
PrimitiveStreak-embryonic cell : 83.43% ;
AnteriorNeuralTube-neural crest cell : 50.10% ;
TotalBrain-Immune cells : 2.21% ;
Nipah henipavirus
PrimitiveStreak-embryonic cell : 83.43% ;
AnteriorNeuralTube-neural crest cell : 32.34% ;
TotalBrain-Immune cells : 0.00% ;
Human papillomavirus type 16
AnteriorNeuralTube-neural crest cell : 83.23% ;
PrimitiveStreak-embryonic cell : 82.29% ;
TotalBrain-Immune cells : 2.73% ;
AnteriorNeuralTube-neural crest cell : 77.64% ;
PrimitiveStreak-embryonic cell : 71.43% ;
TotalBrain-Immune cells : 1.17% ;
Porcine reproductive and respiratory syndrome virus
AnteriorNeuralTube-neural crest cell : 83.23% ;
PrimitiveStreak-embryonic cell : 82.29% ;
TotalBrain-Immune cells : 2.73% ;
Machupo mammarenavirus
PrimitiveStreak-embryonic cell : 81.14% ;
AnteriorNeuralTube-neural crest cell : 69.66% ;
TotalBrain-Immune cells : 3.39% ;
Feline panleukopenia virus
PrimitiveStreak-embryonic cell : 81.14% ;
AnteriorNeuralTube-neural crest cell : 69.66% ;
TotalBrain-Immune cells : 3.39% ;
Mouse mammary tumor virus
PrimitiveStreak-embryonic cell : 81.14% ;
AnteriorNeuralTube-neural crest cell : 69.66% ;
TotalBrain-Immune cells : 3.39% ;
Argentinian mammarenavirus
PrimitiveStreak-embryonic cell : 81.14% ;
AnteriorNeuralTube-neural crest cell : 69.66% ;
TotalBrain-Immune cells : 3.39% ;
Guanarito mammarenavirus
PrimitiveStreak-embryonic cell : 81.14% ;
AnteriorNeuralTube-neural crest cell : 69.66% ;
TotalBrain-Immune cells : 3.39% ;
Canine parvovirus
PrimitiveStreak-embryonic cell : 81.14% ;
AnteriorNeuralTube-neural crest cell : 69.66% ;
TotalBrain-Immune cells : 3.39% ;
Coxsackievirus A16
AnteriorNeuralTube-neural crest cell : 79.24% ;
PrimitiveStreak-embryonic cell : 69.14% ;
TotalBrain-Immune cells : 1.30% ;
Enterovirus A71
AnteriorNeuralTube-neural crest cell : 79.24% ;
PrimitiveStreak-embryonic cell : 69.14% ;
TotalBrain-Immune cells : 1.30% ;
Human mastadenovirus C
PrimitiveStreak-embryonic cell : 74.29% ;
AnteriorNeuralTube-neural crest cell : 69.46% ;
TotalBrain-Immune cells : 19.40% ;
AnteriorNeuralTube-neural crest cell : 64.07% ;
PrimitiveStreak-embryonic cell : 60.00% ;
TotalBrain-Immune cells : 14.58% ;
Human alphaherpesvirus 2
PrimitiveStreak-embryonic cell : 73.71% ;
AnteriorNeuralTube-neural crest cell : 36.33% ;
TotalBrain-Immune cells : 0.00% ;
Suid alphaherpesvirus 1
PrimitiveStreak-embryonic cell : 73.71% ;
AnteriorNeuralTube-neural crest cell : 36.33% ;
TotalBrain-Immune cells : 0.00% ;
Bovine alphaherpesvirus 1
PrimitiveStreak-embryonic cell : 73.71% ;
AnteriorNeuralTube-neural crest cell : 36.33% ;
TotalBrain-Immune cells : 0.00% ;
Human alphaherpesvirus 1
PrimitiveStreak-embryonic cell : 73.71% ;
AnteriorNeuralTube-neural crest cell : 36.33% ;
TotalBrain-Immune cells : 0.00% ;
AnteriorNeuralTube-neural crest cell : 64.07% ;
PrimitiveStreak-embryonic cell : 60.00% ;
TotalBrain-Immune cells : 14.58% ;
PrimitiveStreak-embryonic cell : 16.57% ;
AnteriorNeuralTube-neural crest cell : 12.57% ;
TotalBrain-Immune cells : 0.00% ;
PrimitiveStreak-embryonic cell : 12.00% ;
TotalBrain-Immune cells : 0.00% ;
Human gammaherpesvirus 8
AnteriorNeuralTube-neural crest cell : 64.07% ;
PrimitiveStreak-embryonic cell : 60.00% ;
TotalBrain-Immune cells : 14.58% ;
West Nile virus
AnteriorNeuralTube-neural crest cell : 64.07% ;
PrimitiveStreak-embryonic cell : 60.00% ;
TotalBrain-Immune cells : 14.58% ;
Coxsackievirus B1
AnteriorNeuralTube-neural crest cell : 64.07% ;
PrimitiveStreak-embryonic cell : 60.00% ;
TotalBrain-Immune cells : 14.58% ;
PrimitiveStreak-embryonic cell : 12.00% ;
TotalBrain-Immune cells : 0.00% ;
Human parechovirus 1
AnteriorNeuralTube-neural crest cell : 64.07% ;
PrimitiveStreak-embryonic cell : 60.00% ;
TotalBrain-Immune cells : 14.58% ;
Coxsackievirus A9
AnteriorNeuralTube-neural crest cell : 64.07% ;
PrimitiveStreak-embryonic cell : 60.00% ;
TotalBrain-Immune cells : 14.58% ;
PrimitiveStreak-embryonic cell : 12.00% ;
TotalBrain-Immune cells : 0.00% ;
Severe acute respiratory syndrome coronavirus 2
PrimitiveStreak-embryonic cell : 49.71% ;
AnteriorNeuralTube-neural crest cell : 39.92% ;
TotalBrain-Immune cells : 0.91% ;
AnteriorNeuralTube-neural crest cell : 18.96% ;
PrimitiveStreak-embryonic cell : 8.00% ;
TotalBrain-Immune cells : 7.03% ;
PrimitiveStreak-embryonic cell : 3.43% ;
AnteriorNeuralTube-neural crest cell : 1.40% ;
TotalBrain-Immune cells : 0.00% ;
Sin Nombre orthohantavirus
PrimitiveStreak-embryonic cell : 47.43% ;
AnteriorNeuralTube-neural crest cell : 21.16% ;
TotalBrain-Immune cells : 0.00% ;
Andes orthohantavirus
PrimitiveStreak-embryonic cell : 47.43% ;
AnteriorNeuralTube-neural crest cell : 21.16% ;
TotalBrain-Immune cells : 0.00% ;
Simian sarcoma-associated virus
AnteriorNeuralTube-neural crest cell : 47.11% ;
PrimitiveStreak-embryonic cell : 13.71% ;
TotalBrain-Immune cells : 0.65% ;
Ecotropic murine leukemia virus
PrimitiveStreak-embryonic cell : 46.86% ;
AnteriorNeuralTube-neural crest cell : 44.51% ;
TotalBrain-Immune cells : 0.00% ;
Vesicular stomatitis virus
AnteriorNeuralTube-neural crest cell : 45.11% ;
PrimitiveStreak-embryonic cell : 26.29% ;
TotalBrain-Immune cells : 4.04% ;
Feline coronavirus
AnteriorNeuralTube-neural crest cell : 43.31% ;
PrimitiveStreak-embryonic cell : 3.43% ;
TotalBrain-Immune cells : 0.00% ;
Transmissible gastroenteritis virus
AnteriorNeuralTube-neural crest cell : 43.31% ;
PrimitiveStreak-embryonic cell : 3.43% ;
TotalBrain-Immune cells : 0.00% ;
Infectious bronchitis virus
AnteriorNeuralTube-neural crest cell : 43.31% ;
PrimitiveStreak-embryonic cell : 3.43% ;
TotalBrain-Immune cells : 0.00% ;
Porcine epidemic diarrhea virus
AnteriorNeuralTube-neural crest cell : 43.31% ;
PrimitiveStreak-embryonic cell : 3.43% ;
TotalBrain-Immune cells : 0.00% ;
Canine coronavirus
AnteriorNeuralTube-neural crest cell : 43.31% ;
PrimitiveStreak-embryonic cell : 3.43% ;
TotalBrain-Immune cells : 0.00% ;
Human coronavirus 229E
AnteriorNeuralTube-neural crest cell : 43.31% ;
PrimitiveStreak-embryonic cell : 3.43% ;
TotalBrain-Immune cells : 0.00% ;
Feline calicivirus
AnteriorNeuralTube-neural crest cell : 40.52% ;
PrimitiveStreak-embryonic cell : 22.29% ;
Coxsackievirus A10
AnteriorNeuralTube-neural crest cell : 34.93% ;
PrimitiveStreak-embryonic cell : 29.14% ;
TotalBrain-Immune cells : 0.00% ;
Feline leukemia virus strain C/FA27
PrimitiveStreak-embryonic cell : 32.00% ;
AnteriorNeuralTube-neural crest cell : 27.15% ;
TotalBrain-Immune cells : 0.26% ;
Jaagsiekte sheep retrovirus
AnteriorNeuralTube-neural crest cell : 26.15% ;
PrimitiveStreak-embryonic cell : 15.43% ;
TotalBrain-Immune cells : 0.13% ;
Simian immunodeficiency virus
TotalBrain-Immune cells : 20.83% ;
Hepatitis E virus
AnteriorNeuralTube-neural crest cell : 16.97% ;
PrimitiveStreak-embryonic cell : 10.29% ;
TotalBrain-Immune cells : 0.13% ;
Mayaro virus
PrimitiveStreak-embryonic cell : 15.43% ;
AnteriorNeuralTube-neural crest cell : 10.78% ;
TotalBrain-Immune cells : 0.52% ;
Onyong-nyong virus
PrimitiveStreak-embryonic cell : 15.43% ;
AnteriorNeuralTube-neural crest cell : 10.78% ;
TotalBrain-Immune cells : 0.52% ;
Ross River virus
PrimitiveStreak-embryonic cell : 15.43% ;
AnteriorNeuralTube-neural crest cell : 10.78% ;
TotalBrain-Immune cells : 0.52% ;
Measles morbillivirus
AnteriorNeuralTube-neural crest cell : 12.18% ;
Small ruminant morbillivirus
AnteriorNeuralTube-neural crest cell : 12.18% ;
Canine morbillivirus
AnteriorNeuralTube-neural crest cell : 12.18% ;
Respiratory syncytial virus
TotalBrain-Immune cells : 8.98% ;
Bovine leukemia virus
TotalBrain-Immune cells : 4.69% ;
SARS coronavirus
PrimitiveStreak-embryonic cell : 3.43% ;
AnteriorNeuralTube-neural crest cell : 1.40% ;
TotalBrain-Immune cells : 0.00% ;
Human coronavirus NL63
PrimitiveStreak-embryonic cell : 3.43% ;
AnteriorNeuralTube-neural crest cell : 1.40% ;
TotalBrain-Immune cells : 0.00% ;
Encephalomyocarditis virus
AnteriorNeuralTube-neural crest cell : 1.60% ;
JC polyomavirus
AnteriorNeuralTube-neural crest cell : 1.40% ;
TotalBrain-Immune cells : 0.00% ;
Rubella virus
AnteriorNeuralTube-neural crest cell : 1.00% ;
Human mastadenovirus B
TotalBrain-Immune cells : 0.52% ;
Middle East respiratory syndrome-related coronavirus
TotalBrain-Immune cells : 0.13% ;
Rhinovirus C
TotalBrain-Immune cells : 0.13% ;